Jeroen Wakkerman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pharming N : 1Q 2024 financial results - Analyst & Investor Call transcript

Pharming N : 1Q 2024 financial results - Analyst & Investor Call transcript
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew jerseyUnited statesAsia pacificChristian glennieVan lanschot kempenStephen toorJeroen wakkermanChristian glennie stifelJoe pantginisAlistair campbellHartaj singhSushila hernandezAnurag relanPatient programPharming group

Pharming N : 2Q/1H 2023 Financial Results - Analyst Call Transcript

Pharming Group N.V. 2Q/1H 2023 Results Call August 3, 2023 Rewatch.

Natalia websterFanyi zhongHartaj singhSushila hernandezJeroen wakkermanJoe pantginisPaul sekhriRichard petersAnurag relanAlexandre breidenbachSanofi genzymeChristian glennieStephen toorVan lanschot kempenPharming groupHealth economic research specialists

Pharming Group N V : Pharming announces sale of priority review voucher

LEIDEN, The Netherlands, June 1, 2023 /PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that it has entered into a definitive

Noord hollandCity ofUnited kingdomUnited statesMichael levitanHeather robertsonJeroen wakkermanDrug administrationInvestor relations corporate communicationsPharming groupVp investor relations corporate communicationsPrnewswire pharming groupnvExchange commissionLifespring life sciences communicationNovartis pharmaRare pediatric disease priority review voucher

Pharming announces sale of priority review voucher

/PRNewswire/ Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that it has entered into a definitive.

City ofUnited kingdomUnited statesNoord hollandHeather robertsonJeroen wakkermanMichael levitanDrug administrationInvestor relations corporate communicationsVp investor relations corporate communicationsPharming groupPrnewswire pharming groupnvExchange commissionLifespring life sciences communicationNovartis pharmaRare pediatric disease priority review voucher

Pharming to present at Stifel Healthcare Conference

/PRNewswire/ Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (NASDAQ: PHAR) announces that its Chief Financial Officer, Jeroen Wakkerman, will.

New yorkUnited statesUnited kingdomCity ofNoord hollandJeroen wakkermanHeather robertsonFoster mitchell alex shawJim polsonPharming groupnv euronextamsterdamPharming groupLifespring life sciences communicationInvestor relations corporate communicationsEuronext amsterdamChief financial officerStifel healthcare conference